Comparative Molecular Characterization and Pharmacokinetics of IgG1-Fc and Engineered Fc Human Antibody Variants to Insulin-like Growth Factor 2 Receptor (IGF2R).

MLA

Prabaharan, Chandra B., et al. “Comparative Molecular Characterization and Pharmacokinetics of IgG1-Fc and Engineered Fc Human Antibody Variants to Insulin-like Growth Factor 2 Receptor (IGF2R).” Molecules (Basel, Switzerland), vol. 28, no. 15, Aug. 2023. EBSCOhost, https://doi.org/10.3390/molecules28155839.

APA

Prabaharan, C. B., Giri, S., Allen, K. J. H., Bato, K. E. M., Mercado, T. R., Malo, M. E., Carvalho, J. L. C., Dadachova, E., & Uppalapati, M. (2023). Comparative Molecular Characterization and Pharmacokinetics of IgG1-Fc and Engineered Fc Human Antibody Variants to Insulin-like Growth Factor 2 Receptor (IGF2R). Molecules (Basel, Switzerland), 28(15). https://doi.org/10.3390/molecules28155839

Chicago

Prabaharan, Chandra B, Sabeena Giri, Kevin J H Allen, Katrina E M Bato, Therese R Mercado, Mackenzie E Malo, Jorge L C Carvalho, Ekaterina Dadachova, and Maruti Uppalapati. 2023. “Comparative Molecular Characterization and Pharmacokinetics of IgG1-Fc and Engineered Fc Human Antibody Variants to Insulin-like Growth Factor 2 Receptor (IGF2R).” Molecules (Basel, Switzerland) 28 (15). doi:10.3390/molecules28155839.